INVO Fertility Files 8-K: Investor Presentation Posted; $3.59M Stock Sold

What Happened

• INVO Fertility, Inc. (NASDAQ: IVF) filed an 8-K on August 28, 2026 disclosing two items: (1) it furnished an investor presentation (posted to its website and attached as Exhibit 99.1) that it plans to use at the H.C. Wainwright 28th Annual Global Investment Conference (Sept 14–16, 2026); and (2) an update under its July 24, 2026 Any Market Purchase Agreement with Alumni Capital LP describing recent share sales to that investor.

Key Details

• The investor presentation was posted August 28, 2026 and will be used at the H.C. Wainwright conference (Sept 14–16, 2026).
• Under the July 24, 2026 Purchase Agreement, the Company may sell up to $15.0 million of common stock to Alumni Capital LP (with a potential increase by mutual agreement up to $50.0 million).
• Since the registration statement became effective, INVO sold 2,094,395 shares to the Investor for approximately $3,591,000, at an average price of about $1.71 per share.

Why It Matters

• The presentation provides updated company information for investors and will be used at an upcoming industry conference, which may clarify INVO’s strategy and operations.
• The stock sales under the Purchase Agreement represent a source of capital already accessed by the company ($3.59M) and signal the potential for additional share issuance (up to the stated commitment), which investors should consider in evaluating dilution and capital resources.